NYSE:LHHealthcare
Alzheimer’s Test Launch And 2026 Outlook Might Change The Case For Investing In Labcorp (LH)
In February 2026, Labcorp Holdings reported fourth-quarter 2025 sales of US$3,515.8 million and full-year sales of US$13.95 billion, alongside higher net income and earnings per share from continuing operations year over year, while issuing 2026 revenue guidance of US$14.61 billion to US$14.79 billion.
The company also completed a multi-year US$3.64 billion share repurchase program and expanded its Alzheimer’s testing portfolio with the nationwide launch of the FDA-cleared Elecsys pTau-181...